Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$21.09 USD
+0.91 (4.51%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $21.08 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Balance Sheet
Fiscal Year End for Fresenius Medical Care AG & Co KGaA falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,783 | 1,342 | 1,753 | 1,235 | 1,129 |
Receivables | 3,936 | 3,913 | 4,225 | 3,706 | 4,010 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2,359 | 2,419 | 2,411 | 2,165 | 1,863 |
Other Current Assets | 1,340 | 968 | 1,037 | 1,204 | 1,023 |
Total Current Assets | 9,418 | 8,643 | 9,426 | 8,311 | 8,025 |
Net Property & Equipment | 4,094 | 4,375 | 5,010 | 4,634 | 4,693 |
Investments & Advances | 1,358 | 815 | 931 | 869 | 781 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 307 | 329 | 373 | 401 | 405 |
Intangibles | 17,330 | 18,238 | 18,718 | 16,380 | 17,297 |
Deposits & Other Assets | 242 | 858 | 1,094 | 885 | 843 |
Total Assets | 36,722 | 37,671 | 40,659 | 36,198 | 36,887 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 958 | 981 | 1,015 | 945 | 935 |
Current Portion Long-Term Debt | 1,022 | 1,436 | 2,276 | 1,242 | 2,933 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 207 | 152 | 163 | 135 | 114 |
Other Current Liabilities | 3,759 | 3,535 | 4,350 | 4,018 | 3,150 |
Total Current Liabilities | 6,615 | 6,814 | 8,587 | 7,036 | 7,848 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 812 | 987 | 1,027 | 898 | 828 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 7,533 | 7,555 | 7,864 | 7,768 | 7,233 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1,897 | 1,818 | 1,806 | 1,975 | 1,608 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 20,675 | 21,393 | 24,120 | 22,112 | 22,072 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 318 | 309 | 347 | 335 | 341 |
Capital Surplus | 3,659 | 3,554 | 3,421 | 3,281 | 4,041 |
Retained Earnings | 11,821 | 11,286 | 12,808 | 11,714 | 10,589 |
Other Equity | 250 | 1,129 | -37 | -1,244 | 258 |
Treasury Stock | 0 | 0 | 0 | 0 | 415 |
Total Shareholder's Equity | 16,047 | 16,277 | 16,539 | 14,086 | 14,815 |
Total Liabilities & Shareholder's Equity | 36,722 | 37,671 | 40,659 | 36,198 | 36,887 |
Total Common Equity | 16,047 | 16,277 | 16,539 | 14,086 | 14,815 |
Shares Outstanding | 586.80 | 586.80 | 585.90 | 585.60 | 596.60 |
Book Value Per Share | 27.35 | 27.74 | 28.23 | 24.05 | 24.83 |
Fiscal Year End for Fresenius Medical Care AG & Co KGaA falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,517 | 1,518 | 1,783 | 1,691 | 1,484 |
Receivables | 4,375 | 4,397 | 3,936 | 4,043 | 3,976 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2,399 | 2,406 | 2,359 | 2,508 | 2,547 |
Other Current Assets | 1,068 | 1,756 | 1,340 | 1,614 | 1,095 |
Total Current Assets | 9,358 | 10,078 | 9,418 | 9,855 | 9,102 |
Net Property & Equipment | 3,930 | 3,988 | 4,094 | 4,286 | 4,311 |
Investments & Advances | 1,479 | 1,417 | 1,358 | 767 | 759 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 299 | 291 | 307 | 331 | 342 |
Intangibles | 17,405 | 17,410 | 17,330 | 18,300 | 18,345 |
Deposits & Other Assets | 142 | 150 | 242 | 949 | 925 |
Total Assets | 36,503 | 37,279 | 36,722 | 38,785 | 38,121 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 981 | 907 | 958 | 919 | 893 |
Current Portion Long-Term Debt | 865 | 982 | 1,022 | 1,368 | 1,751 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 150 | 245 | 207 | 242 | 211 |
Other Current Liabilities | 3,733 | 3,932 | 3,759 | 3,967 | 3,658 |
Total Current Liabilities | 6,392 | 6,735 | 6,615 | 7,204 | 7,223 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 748 | 772 | 812 | 929 | 942 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 7,381 | 7,618 | 7,533 | 7,907 | 7,630 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1,880 | 1,897 | 1,807 | 1,890 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 20,148 | 20,850 | 20,675 | 21,986 | 21,841 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 316 | 319 | 318 | 319 | 320 |
Capital Surplus | 3,647 | 3,676 | 3,659 | 3,677 | 3,676 |
Retained Earnings | 11,708 | 11,972 | 11,821 | 11,710 | 11,605 |
Other Equity | 684 | 463 | 250 | 1,093 | 679 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 16,355 | 16,429 | 16,047 | 16,799 | 16,280 |
Total Liabilities & Shareholder's Equity | 36,503 | 37,279 | 36,722 | 38,785 | 38,121 |
Total Common Equity | 16,355 | 16,429 | 16,047 | 16,799 | 16,280 |
Shares Outstanding | 586.80 | 586.80 | 586.80 | 586.80 | 586.80 |
Book Value Per Share | 27.87 | 28.00 | 27.35 | 28.63 | 27.74 |